Yamanaka eliminates viral vector in stem cell reprogramming
Sunday, October 12, 2008 - 08:35
in Health & Medicine
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent stem (iPS) cell technology.